SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-24-097440
Filing Date
2024-11-13
Accepted
2024-11-13 16:01:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G ea0221067-13ga2knight_60deg.htm SC 13G/A 60249
  Complete submission text file 0001213900-24-097440.txt   61913
Mailing Address 3400 BOULEVARD DE MAISONNEUVE WEST SUITE 1055 MONTREAL A8 H3Z 3B8
Business Address 3400 BOULEVARD DE MAISONNEUVE WEST SUITE 1055 MONTREAL A8 H3Z 3B8 5144844483
Knight Therapeutics Inc (Filed by) CIK: 0001756235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Subject) CIK: 0001946563 (see all company filings)

IRS No.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-94258 | Film No.: 241453845
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)